Literature DB >> 12607150

Minimal neuropsychological assessment of MS patients: a consensus approach.

Ralph H B Benedict1, Jill S Fischer, Cate J Archibald, Peter A Arnett, William W Beatty, Julie Bobholz, Gordon J Chelune, John D Fisk, Dawn W Langdon, Lauren Caruso, Fred Foley, Nicholas G LaRocca, Lindsey Vowels, Amy Weinstein, John DeLuca, Stephen M Rao, Frederick Munschauer.   

Abstract

Cognitive impairment is common in multiple sclerosis (MS), yet patients seen in MS clinics and neurologic practices are not routinely assessed neuropsychologically. In part, poor utilization of NP services may be attributed to a lack of consensus among neuropsychologists regarding the optimal approach for evaluating MS patients. An expert panel composed of neuropsychologists and psychologists from the United States, Canada, United Kingdom, and Australia was convened by the Consortium of MS Centers (CMSC) in April, 2001. Our objectives were to: (a) propose a minimal neuropsychological (NP) examination for clinical monitoring of MS patients and research, and (b) identify strategies for improving NP assessment of MS patients in the future. The panel reviewed pertinent literature on MS-related cognitive dysfunction, considered psychometric factors relevant to NP assessment, defined the purpose and optimal characteristics of a minimal NP examination in MS, and rated the psychometric and practical properties of 36 candidate NP measures based on available literature. A 90-minute NP battery, the Minimal Assessment of Cognitive Function in MS (MACFIMS), emerged from this discussion. The MACFIMS is composed of seven neuropsychological tests, covering five cognitive domains commonly impaired in MS (processing speed/working memory, learning and memory, executive function, visual-spatial processing, and word retrieval). It is supplemented by a measure of estimated premorbid cognitive ability. Recommendations for assessing other factors that may potentially confound interpretation of NP data (e.g., visual/sensory/motor impairment, fatigue, and depression) are offered, as well as strategies for improving NP assessment of MS patients in the future.

Entities:  

Mesh:

Year:  2002        PMID: 12607150     DOI: 10.1076/clin.16.3.381.13859

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  128 in total

1.  Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.

Authors:  L B Krupp; C Christodoulou; P Melville; W F Scherl; L-Y Pai; L R Muenz; D He; R H B Benedict; A Goodman; S Rizvi; S R Schwid; B Weinstock-Guttman; H J Westervelt; H Wishart
Journal:  Neurology       Date:  2011-04-26       Impact factor: 9.910

2.  A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis.

Authors:  Alexa K Stuifbergen; Heather Becker; Frank Perez; Janet Morison; Vicki Kullberg; Ana Todd
Journal:  Clin Rehabil       Date:  2012-02-02       Impact factor: 3.477

3.  Capacity for financial decision making in multiple sclerosis.

Authors:  Victoria L Tracy; Michael R Basso; Daniel C Marson; Dennis R Combs; Douglas M Whiteside
Journal:  J Clin Exp Neuropsychol       Date:  2016-07-19       Impact factor: 2.475

Review 4.  [Cognitive dysfunctions in multiple sclerosis patients].

Authors:  C Engel; B Greim; U K Zettl
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

Review 5.  Reliability and validity of neuropsychological screening and assessment strategies in MS.

Authors:  Ralph H B Benedict; Robert Zivadinov
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

6.  Visual search as a tool for a quick and reliable assessment of cognitive functions in patients with multiple sclerosis.

Authors:  Kathrin S Utz; Thomas M A Hankeln; Lena Jung; Alexandra Lämmer; Anne Waschbisch; De-Hyung Lee; Ralf A Linker; Thomas Schenk
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

7.  Validity of the Verbal Concept Attainment Test in multiple sclerosis.

Authors:  Ryan Mulligan; Michael R Basso; Lily Lau; Bradley Reynolds; Douglas M Whiteside; Dennis Combs; Robert A Bornstein
Journal:  J Clin Exp Neuropsychol       Date:  2019-01-14       Impact factor: 2.475

8.  Feasibility and Findings from a Novel Working Memory fMRI Paradigm in Multiple Sclerosis.

Authors:  F Nelson; J Steinberg
Journal:  J Neurol Disord Stroke       Date:  2013-09

9.  Functional magnetic resonance imaging movers and shakers: does subject-movement cause sampling bias?

Authors:  Glenn R Wylie; Helen Genova; John DeLuca; Nancy Chiaravalloti; James F Sumowski
Journal:  Hum Brain Mapp       Date:  2012-07-30       Impact factor: 5.038

10.  Regional Frontal Perfusion Deficits in Relapsing-Remitting Multiple Sclerosis with Cognitive Decline.

Authors:  R Vitorino; S-P Hojjat; C G Cantrell; A Feinstein; L Zhang; L Lee; P O'Connor; T J Carroll; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-19       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.